EUVIMEDEUVIMED entdecken
Open Access

Molecular and Phylogenetic Characterization of HTLV‐1 Infection in Patients With Hematological Malignancies in the State of Pará, Northern Brazil

Gabriel Dos Santos Pereira Neto, Ana Vilhena Alves, Bruno José Sarmento Botelho, Andrio Silva da Silva, Debora Monteiro Carneiro, Rommel Mario Rodriguez Burbano, Ricardo Ishak, Antonio Carlos Rosário Vallinoto, Izaura Maria Vieira Cayres Vallinoto

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.71024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Gabriel Dos Santos Pereira Neto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil. Hauptthemen laut MEDLINE: HTLV-I Infections, Human T-lymphotropic virus 1, Phylogeny, Hematologic Neoplasms. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Amazônia de Amparo a Estudos e Pesquisa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human T‐lymphotropic viruses 1 and 2 (HTLV‐1 and HTLV‐2) were first isolated from patients with hematological malignancies. This study was the first to investigate the frequency of HTLV‐1 and its molecular diversity among patients with hematolymphoid cancers who were treated at a leading reference hospital in Pará, northern Brazil. For this purpose, information from the International Classification of Diseases (ICD), laboratory test records, and peripheral blood samples were obtained. Patients with confirmed diagnosis of leukemia/lymphoma, myeloma, other hematological malignancies, and those under diagnostic investigation were included in the study. Serological screening for anti‐HTLV‐1/2 antibodies was carried out by ELISA, and infection was confirmed by real‐time PCR. PCR‐positive samples were sequenced for phylogenetic analysis. Of 329 people assessed, 47.7% were men (157) and 52.3% were women (172). The overall prevalence of HTLV‐1 was 1.82% (6/329), with 2.5% ( n = 4) in men and 1.2% ( n = 2) in women. Phylogenetic analysis of the 5′LTR region (715 bp) of HTLV‐1 indicated that the isolates belonged to the Cosmopolitan subtype, Transcontinental subgroup. Positivity among patients with lymphoma was 6.56% (4/61), with one patient diagnosed with Hodgkin lymphoma. Among patients under clinical investigation and with other types of cancer, the prevalence of infection was 1.19% (1/84) and 2.38% (1/42), respectively. A decrease in red blood cell count, hemoglobin, and hematocrit was identified in cancer patients with a negative HTLV diagnosis compared to HTLV‐positive patients. Our results highlight the importance of including HTLV‐1/2 testing in the routine follow‐up of cancer patients, for the sake of existing successful treatment protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HTLV-I InfectionsHuman T-lymphotropic virus 1PhylogenyHematologic NeoplasmsGenetic VariationHumansFemaleBrazilMaleMiddle AgedAdultPrevalenceSequence Analysis, DNAAgedYoung AdultAdolescentEnzyme-Linked Immunosorbent AssayGenotypeReal-Time Polymerase Chain ReactionAged, 80 and overCluster AnalysisMolecular Sequence DataTerminal Repeat SequencesHTLV-I AntibodiesMolecular Epidemiology

Stichwörter der Autor:innen

HTLV‐1leukemialymphomaneoplasmsoncoviruses

Substanzen

HTLV-I Antibodies

Autor:innen und Institutionen

  • Laboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
  • Postgraduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
  • INCT-UroGen, National Institute of Science, Technology and Innovation in Genitourinary Cancer, Brazil.
  • Human Cytogenetics Laboratory, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
  • Molecular Biology Laboratory, Ophir Loyola Hospital, Belém, Brazil.
  • INCT-VER, National Institute of Science, Technology and Innovation in Emerging and Re-emerging Viral Diseases, Brazil.

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Amazônia de Amparo a Estudos e Pesquisa

Zitieren

APA

Neto, G. D. S. P., Alves, A. V., Botelho, B. J. S., Silva, A. S. D., Carneiro, D. M., Burbano, R. M. R., Ishak, R., Vallinoto, A. C. R., & Vallinoto, I. M. V. C. (2026). Molecular and Phylogenetic Characterization of HTLV‐1 Infection in Patients With Hematological Malignancies in the State of Pará, Northern Brazil. Journal of Medical Virology. https://doi.org/10.1002/jmv.71024

Vancouver

Neto GDSP, Alves AV, Botelho BJS, Silva ASD, Carneiro DM, Burbano RMR, et al. Molecular and Phylogenetic Characterization of HTLV‐1 Infection in Patients With Hematological Malignancies in the State of Pará, Northern Brazil. Journal of Medical Virology. 2026. doi:10.1002/jmv.71024

BibTeX
@article{Neto2026,
  author = {Neto, Gabriel Dos Santos Pereira and Alves, Ana Vilhena and Botelho, Bruno José Sarmento and Silva, Andrio Silva da and Carneiro, Debora Monteiro and Burbano, Rommel Mario Rodriguez and Ishak, Ricardo and Vallinoto, Antonio Carlos Rosário and Vallinoto, Izaura Maria Vieira Cayres},
  title = {Molecular and Phylogenetic Characterization of HTLV‐1 Infection in Patients With Hematological Malignancies in the State of Pará, Northern Brazil},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.71024}
}
Kostenlos starten →